Gilboa, Eli
University of Miami,
United States
2025 Rank: 95921
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1771 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 95921 | 109705 |
| Total Cites | 501 | 513 |
| H-index | 11 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 22 | 22 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 47 | 47 |
| Number of Single+First+Last Authored Papers | 100 | 100 |
| Total Cites to Single+First+Last Authored Papers | 195 | 202 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 428 | 436 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
2.34%
|
|
Gilboa, Eli
Sylvester Comprehensive Cancer Center,
United States
2024 Rank: 74556
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1503 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74556 | 89647 |
| Total Cites | 562 | 583 |
| H-index | 12 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 22 | 22 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 40 | 40 |
| Number of Single+First+Last Authored Papers | 99 | 99 |
| Total Cites to Single+First+Last Authored Papers | 229 | 232 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 461 | 479 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.22 |
| Self-Citation Percentage |
3.60%
|
|
Gilboa, Eli
Sylvester Comprehensive Cancer Center,
United States
2023 Rank: 56733
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1244 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56733 | 63941 |
| Total Cites | 625 | 671 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 32 | 32 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 53 | 54 |
| Number of Single+First+Last Authored Papers | 99 | 99 |
| Total Cites to Single+First+Last Authored Papers | 263 | 284 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 490 | 505 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.33 |
| Self-Citation Percentage |
6.86%
|
|
Gilboa, Eli
Sylvester Comprehensive Cancer Center,
United States
2022 Rank: 46316
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1169 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46316 | 52709 |
| Total Cites | 632 | 677 |
| H-index | 13 | 13 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 31 | 31 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 60 | 60 |
| Number of Single+First+Last Authored Papers | 98 | 98 |
| Total Cites to Single+First+Last Authored Papers | 259 | 273 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 495 | 520 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.30 |
| Self-Citation Percentage |
6.65%
|
|
Gilboa, Eli
Sylvester Comprehensive Cancer Center,
United States
2021 Rank: 45429
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1061 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45429 | 50227 |
| Total Cites | 993 | 1041 |
| H-index | 17 | 18 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 48 | 48 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 82 | 82 |
| Number of Single+First+Last Authored Papers | 94 | 94 |
| Total Cites to Single+First+Last Authored Papers | 366 | 379 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 751 | 783 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.33 |
| Self-Citation Percentage |
4.61%
|
|
Gilboa, Eli
University of Miami Leonard M. Miller School of Medicine,
United States
2020 Rank: 39445
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 883 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39445 | 45464 |
| Total Cites | 660 | 705 |
| H-index | 13 | 13 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 50 | 50 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 76 | 77 |
| Number of Single+First+Last Authored Papers | 96 | 96 |
| Total Cites to Single+First+Last Authored Papers | 273 | 287 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 525 | 556 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
6.38%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.